Orencia clickject 125 MG/mlml
Ended Awarded
- Contract number
- SPE2DB25FQHKW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,542
Award facts
- Contract value 100% obligated
- $9,541.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,541.68 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, issued on July 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. No set-aside designation was applied to this award, indicating it was competitively awarded.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor serving federal medical procurement needs, is fulfilling this delivery order as part of its comprehensive pharmaceutical prime vendor role supporting military healthcare systems. The DLA Troop Support Medical contract enables AmerisourceBergen to supply a vast range of pharmaceutical products, specialty medications, vaccines, and medical devices globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. This delivery order reflects the company's established capability in providing branded and generic pharmaceuticals on a firm fixed-price basis, with an ultimate completion date of August 1, 2025.
Quick answers
Who was awarded contract SPE2DB25FQHKW?
SPE2DB25FQHKW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FQHKW worth?
The government has obligated $9,542 on SPE2DB25FQHKW.
Is contract SPE2DB25FQHKW an order under another contract?
Yes. SPE2DB25FQHKW is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHKW competed?
The extent of competition for SPE2DB25FQHKW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award